Filtros de búsqueda

Lista de obras de

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical T

scientific article published on 23 July 2020

DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial

artículo científico publicado en 2017

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

artículo científico publicado en 2020

Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint

scholarly article published in NPJ breast cancer

Estrogen regulation of transforming growth factor-α in ovarian cancer ⬇️

artículo científico publicado el 1 de febrero de 1998

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

artículo científico publicado en 2021

Growth-control of human ovarian-carcinoma cells by insulin-like growth-factors ⬇️

artículo científico publicado el 1 de septiembre de 1995

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial

artículo científico publicado en 2019

Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial

artículo científico publicado en 2020

Mutational signatures in tumours induced by high and low energy radiation in Trp53 deficient mice

scientific article published on 20 January 2020

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint

artículo científico publicado en 2018

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents ⬇️

artículo científico publicado el 3 de julio de 1997

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda